Johanna Richter
Brisbane, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
An mRNA vaccine encoding five conserved Group A Streptococcus antigens.
Journal: Nature communications
Published: January 17, 2025
Efficacy of Alum-Adjuvanted Peptide and Carbohydrate Conjugate Vaccine Candidates against Group A Streptococcus Pharyngeal Infection in a Non-Human Primate Model.
Journal: Vaccines
Published: March 01, 2024
Streptolysins are the primary inflammasome activators in macrophages during Streptococcus pyogenes infection.
Journal: Immunology and cell biology
Published: June 22, 2021
Inflammasome activation and IL-1β signalling in group A Streptococcus disease.
Journal: Cellular microbiology
Published: April 30, 2021
Vaccine-Induced Th1-Type Response Protects against Invasive Group A Streptococcus Infection in the Absence of Opsonizing Antibodies.
Journal: mBio
Published: March 12, 2020
Prophage exotoxins enhance colonization fitness in epidemic scarlet fever-causing Streptococcus pyogenes.
Journal: Nature communications
Published: December 21, 2019
Detection of Epidemic Scarlet Fever Group A Streptococcus in Australia.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 19, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026